Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combination therapy for BPH is cost-effective, especially for men with larger prostates.

Certain treatments can increase protein binding to natural hair but are less effective on permed hair.

The GNP crosslinked scaffold with antibacterial coating is effective for rapid wound healing and infection prevention.

Genetic mutations that disrupt homocysteine breakdown lead to increased damage in mouse hair keratin.

Mediterranean Erica species have compounds that support their traditional use for health benefits like reducing inflammation and fighting infections.

Vesicle-based therapies from stem cells and plants improve burn healing and could be safe, scalable alternatives to cell transplants.

Synthetic hair implants can cause scalp cancer years later.

Skin stretching can improve vaccine delivery through hair follicles and boost immune response.

Organically grown carrots have less heavy metal content and are safer to eat.

Low-dose rapamycin microdepots can help regrow hair by activating certain cell processes.

A rare genetic variant linked to skin cysts was found in blood DNA, suggesting its role in cyst formation.

Telogen effluvium patients have a worse quality of life, but similar self-esteem compared to others.

Hair transplants are better for severe hair loss, while scalp micropigmentation suits those with denser hair.

Teak leaf extract may effectively and safely promote hair growth in males with androgenic alopecia.

The KRTAP15-1 gene affects cashmere fiber thickness in goats.

Mice hair follicles take in the amino acid cystine.

The methods accurately measured brain androgens, showing most 5α-androstane-3α,17β-diol comes from outside the brain, while androsterone is both transported and made in the brain.

4-azasteroids, including finasteride, can inhibit 5α-reductase, helping treat conditions like enlarged prostate and hair loss.

Photoacoustic imaging can detect prostate brachytherapy seeds better with enhanced contrast methods, but depth limits remain.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

2,5-DBH shows promise for improving drugs in cancer, brain disorders, and infections.

The compounds tested could potentially treat hair loss and alopecia.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Drugs localize differently in hair strands based on their properties.